CD8A and non-small cell lung carcinoma: In patients with NSCLC, CD8+TRM cells overexpress several T cell inhibitory receptors and exhaustion surface markers and co-express PD-1 and CD39, implying that they are enriched in activated tumor-antigen reactive T cells (74).